Found 385 matching trials
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
EARLY_PHASE1The purpose of this study is to evaluate the efficacy and safety of allogen...
Location
Institute of Hematology & Blood Diseases Hospital
Donor CHIP and Allogeneic HSCT Outcome
N/ACurrent data on the impact of donor CHIP on long-term recipient outcome rem...
Location
The University of Hong Kong
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
PHASE1The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
A Study of FMT in Patients With AML Allo HSCT in Recipients
PHASE2This is a randomized, double-blind, placebo-controlled clinical trial of Fe...
Location
Masonic Cancer Center at University of Minnesota
Allo HSCT Using RIC for Hematological Diseases
PHASE2This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Location
Masonic Cancer Center at University of Minnesota
Busulfan and Cyclophosphamide Followed By ALLO BMT
NAThis is a treatment guideline to allow routine clinical data to be collecte...
Location
Masonic Cancer Center, University of Minnesota
Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV
NAThis is a clinical study on the efficacy and safety of low-dose CD20 monocl...
Location
Beijing Friendship Hospital
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
NAThis is a biological study for adult MDS patients who undergo HSCT procedur...
Location
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
PHASE2The researchers are doing this study to compare 2 different GVHD prevention...
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
PHASE1To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Location
Peking University People's Hospital